ATE500268T1 - Peptide mit neuropeptide-2 rezeptor agonist aktivität - Google Patents

Peptide mit neuropeptide-2 rezeptor agonist aktivität

Info

Publication number
ATE500268T1
ATE500268T1 AT06700451T AT06700451T ATE500268T1 AT E500268 T1 ATE500268 T1 AT E500268T1 AT 06700451 T AT06700451 T AT 06700451T AT 06700451 T AT06700451 T AT 06700451T AT E500268 T1 ATE500268 T1 AT E500268T1
Authority
AT
Austria
Prior art keywords
neuropeptide
peptides
receptor agonist
agonist activity
activity
Prior art date
Application number
AT06700451T
Other languages
English (en)
Inventor
Waleed Danho
George Ehrlich
David Fry
Wajiha Khan
Joseph Swistok
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE500268T1 publication Critical patent/ATE500268T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57545—Neuropeptide Y
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06700451T 2005-01-18 2006-01-11 Peptide mit neuropeptide-2 rezeptor agonist aktivität ATE500268T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64484005P 2005-01-18 2005-01-18
PCT/EP2006/000161 WO2006077035A1 (en) 2005-01-18 2006-01-11 Peptides with neuropeptide-2 receptor (y2r) agonist activity

Publications (1)

Publication Number Publication Date
ATE500268T1 true ATE500268T1 (de) 2011-03-15

Family

ID=36118121

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06700451T ATE500268T1 (de) 2005-01-18 2006-01-11 Peptide mit neuropeptide-2 rezeptor agonist aktivität

Country Status (22)

Country Link
US (1) US7410949B2 (de)
EP (1) EP1844070B1 (de)
JP (1) JP4633804B2 (de)
KR (1) KR100905380B1 (de)
CN (1) CN101107266A (de)
AR (1) AR051904A1 (de)
AT (1) ATE500268T1 (de)
AU (1) AU2006207659B2 (de)
BR (1) BRPI0606675A2 (de)
CA (1) CA2594423A1 (de)
DE (1) DE602006020407D1 (de)
DK (1) DK1844070T3 (de)
ES (1) ES2359850T3 (de)
IL (1) IL184428A0 (de)
MX (1) MX2007008614A (de)
NO (1) NO20073664L (de)
PL (1) PL1844070T3 (de)
PT (1) PT1844070E (de)
RU (1) RU2383553C2 (de)
TW (1) TWI309653B (de)
WO (1) WO2006077035A1 (de)
ZA (1) ZA200705674B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ568772A (en) * 2005-12-07 2010-05-28 Hoffmann La Roche Truncated analogs of the peptide pYY3-36 that are neuropeptide-2 receptor-agonists
US8299023B2 (en) * 2008-09-17 2012-10-30 Hoffmann-La Roche Inc. Neuropeptide-2 receptor (Y-2R) agonists
EP2352511A2 (de) * 2008-11-05 2011-08-10 F. Hoffmann-La Roche AG Neuropeptid-2-rezeptor (y-2r)-agonisten und ihre verwendung
WO2011002066A1 (ja) * 2009-07-02 2011-01-06 武田薬品工業株式会社 ペプチド及びその用途
EP2477643A1 (de) * 2009-09-18 2012-07-25 Novo Nordisk A/S V2-rezeptoragonisten mit langzeitwirkung
EP2488195A2 (de) * 2009-10-13 2012-08-22 F. Hoffmann-La Roche AG Neuropeptid-2-rezeptor (y-2r)-agonisten
PT2651398T (pt) 2010-12-16 2018-03-09 Novo Nordisk As Composições sólidas compreendendo um agonista de glp-1 e um sal de ácido n-(8-(2-hidroxibenzoil)amino) caprílico
HUE062740T2 (hu) 2012-03-22 2023-12-28 Novo Nordisk As GLP-1 peptidek készítményei és elõállításuk
CA2872213A1 (en) 2012-06-13 2013-12-19 F. Hoffmann-La Roche Ag New diazaspirocycloalkane and azaspirocycloalkane
UA116547C2 (uk) 2012-09-25 2018-04-10 Ф. Хоффманн-Ля Рош Аг Біциклічні похідні
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
SI3068421T1 (sl) 2013-11-15 2019-08-30 Novo Nordisk A/S Selektivne spojine PYY in njihova uporaba
EP3068795B1 (de) 2013-11-15 2019-03-06 Novo Nordisk A/S Beta-homoarginin substitution an position 35 von hpyy(1-36)
CN105764905B (zh) 2013-11-26 2019-06-07 豪夫迈·罗氏有限公司 新的八氢-环丁二烯并[1，2-c；3，4-c’]二吡咯-2基
CA2935612A1 (en) 2014-03-26 2015-10-01 F. Hoffmann-La Roche Ag Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors
HUE046820T2 (hu) 2014-03-26 2020-03-30 Hoffmann La Roche Biciklusos vegyületek autotaxin (ATX) és lizofoszfatidsav (LPA) termelésgátlókként
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
BR112017025108A2 (pt) 2015-06-12 2018-07-31 Novo Nordisk As compostos seletivos de pyy e usos dos mesmos
CR20180058A (es) 2015-09-04 2018-02-26 Hoffmann La Roche Nuevos derivados de fenoximetilo
CA2991615A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag Bicyclic compounds as atx inhibitors
JP6846414B2 (ja) 2015-09-24 2021-03-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ａｔｘ阻害剤としての二環式化合物
CN107614505B (zh) 2015-09-24 2021-05-07 豪夫迈·罗氏有限公司 作为双重atx/ca抑制剂的新型二环化合物
EP3353178B1 (de) 2015-09-24 2021-07-14 F. Hoffmann-La Roche AG Bicyclische verbindungen als dual atx/ca hemmer
CN110382484B (zh) 2017-03-16 2022-12-06 豪夫迈·罗氏有限公司 新的作为atx抑制剂的二环化合物
KR20190129924A (ko) 2017-03-16 2019-11-20 에프. 호프만-라 로슈 아게 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 유용한 헤테로환형 화합물
EP3717508A1 (de) 2017-12-01 2020-10-07 The University of Copenhagen Peptidhormon mit einem oder mehreren o-glykanen
BR112020014624A2 (pt) 2018-02-02 2020-12-08 Novo Nordisk A/S Composições sólidas compreendendo agonista de glp-1, sal de ácido n-(8-(2-hidroxibenzoil) amino)caprílico e lubrificante
EP3800195A1 (de) * 2019-10-03 2021-04-07 Universitat de Barcelona Peptidverbindungen zur reduzierung der nebenwirkungen von cb1-rezeptoragonisten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
WO1994022467A1 (en) 1993-03-29 1994-10-13 University Of Cincinnati Analogs of peptide yy and uses thereof
US6017879A (en) * 1998-04-03 2000-01-25 B.M.R.A. Corporation B.V. Template associated NPY Y2-receptor agonists
US7811989B2 (en) * 2003-01-17 2010-10-12 Ipsen Pharma S.A.S. Peptide YY analogs
WO2005053726A1 (en) * 2003-11-25 2005-06-16 Bayer Pharmaceuticals Corporation Selective neuropeptide y2 receptor agonists
EP1789440A4 (de) * 2004-02-11 2008-03-12 Amylin Pharmaceuticals Inc Pankreas-polypeptidfamilienmotive und diese enthaltende polypeptide

Also Published As

Publication number Publication date
EP1844070B1 (de) 2011-03-02
DK1844070T3 (da) 2011-06-14
PL1844070T3 (pl) 2011-07-29
US7410949B2 (en) 2008-08-12
NO20073664L (no) 2007-09-28
RU2383553C2 (ru) 2010-03-10
DE602006020407D1 (de) 2011-04-14
BRPI0606675A2 (pt) 2009-07-07
RU2007131504A (ru) 2009-02-27
KR100905380B1 (ko) 2009-06-30
AU2006207659B2 (en) 2009-10-29
MX2007008614A (es) 2007-09-11
EP1844070A1 (de) 2007-10-17
PT1844070E (pt) 2011-05-04
ZA200705674B (en) 2009-08-26
WO2006077035A1 (en) 2006-07-27
KR20070095422A (ko) 2007-09-28
AR051904A1 (es) 2007-02-14
JP2008527017A (ja) 2008-07-24
WO2006077035A9 (en) 2006-10-26
TW200637874A (en) 2006-11-01
IL184428A0 (en) 2007-10-31
JP4633804B2 (ja) 2011-02-16
ES2359850T3 (es) 2011-05-27
CN101107266A (zh) 2008-01-16
TWI309653B (en) 2009-05-11
US20060160742A1 (en) 2006-07-20
CA2594423A1 (en) 2006-07-27
AU2006207659A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
ATE500268T1 (de) Peptide mit neuropeptide-2 rezeptor agonist aktivität
FR22C1054I2 (fr) Amides peptidiques synthetiques
DK1776133T3 (da) Peptid-vasopressin-receptor-agonister
ATE480555T1 (de) Antimykotische polypeptide
DE602005015131D1 (de) Interleukin-15-antagonistisches peptid
CU23872B1 (es) Anticuerpos antagonistas dirigidos contra el péptido relacionado con el gen de calcitonina
BRPI0818288A2 (pt) Proteínas conjugadas e peptídeos.
DK1973886T3 (da) Prokineticin-1-receptor-antagonister
DE602006007563D1 (de) Agonisten
DK2602263T3 (da) Polypeptider omfattende en isbindende aktivitet
ATE382034T1 (de) Hydroisoindolin-tachykininrezeptorantagonisten
GB2429976B (en) Repeatable protein arrays
ATE482281T1 (de) Plastiden transit peptide
DK2035447T3 (da) Polypeptid
ATE549350T1 (de) Neuropeptid-2-rezeptor-agonisten
IS8482A (is) Kalsítóníngen-skyldir peptíðviðtaka antagónistar
DK2160221T3 (da) Cykliske peptid-CXCR4-antagonister
IL184284A0 (en) Modified beta thymosin peptides
IL189922A0 (en) Selective vpac2 receptor peptide agonists
DE602006006428D1 (de) Material mit trennbarer struktur
DK2468292T3 (da) Nyt peptid med antisekretorisk aktivitet
ATE397618T1 (de) Peptidcyclisierung
DK1809660T3 (da) Thymus-specifikt protein
DK2207790T3 (da) Biologisk aktive C-terminalt argininholdige peptider
DK1968623T3 (da) Bacteriocin-inducer-peptider

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1844070

Country of ref document: EP